| Name | GLP-1 receptor agonist 7 |
|---|---|
| Synonyms |
GLP-1 rector agonist 7
3H-Imidazo[4,5-b]pyridine-5-cboxylic acid, 2-[[4-[(3S)-3-(4-chloro-2-fluorophenyl)-2,3-dihydro-1,4-benzodioxin-5-yl]-1-piperidinyl]methyl]-3-[(2S)-2-oxetanylmethyl] |
| Description | GLP-1 receptor agonist 7 is a potent agonist of glucagon-like peptide-1 (GLP-1). GLP-1 receptor agonist 7 has the potential for the research of GLP-1-associated diseases, disorders, and conditions including diabetes mellitus (extracted from patent WO2021219019A1, compound 130b)[1]. |
|---|---|
| Related Catalog | |
| Target |
GLP-1[1] |
| References |
[1]. Qinghua Meng, et al. Heterocyclic glp-1 agonists. Patent WO2021219019A1. |
| Molecular Formula | C31H30ClFN4O5 |
|---|---|
| Molecular Weight | 593.05 |